NLRP3 and triple-A syndrome: Purinergic receptor P2X7 attenuated aneurysm formation in experimental murine AAA models by inhibiting the activation of the NLRP3 inflammasome, thus inhibiting the cleavage of downstream caspase-1 and the initiation of the pyroptosis pathway 81.